FDA Alert Confirms Heart and Cancer Risks With Tofacitinib ...Middle East

Medscape - News
The FDA has alerted the public to an increased risk of serious heart-related problems and cancer risk associated with the Janus kinase inhibitor tofacitinib (Xeljanz, Xeljanz XR). News Alerts

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Alert Confirms Heart and Cancer Risks With Tofacitinib )

Apple Storegoogle play

Also on site :

Most viewed in News